Literature DB >> 19273075

The NMN/NaMN adenylyltransferase (NMNAT) protein family.

Corinna Lau1, Marc Niere, Mathias Ziegler.   

Abstract

NAD biosynthesis has become of considerable interest owing to the important signaling functions of the pyridine nucleotides which have been recognized over the past years. The formation of the dinucleotides from ATP and the mononucleotide of niacin (either nicotinamide or nicotinic acid) constitute the critical step in NAD generation which is catalyzed by NMN/NaMN adenylyltransferases, NMNATs. Recent research has established the molecular, catalytic and structural properties of NMNATs from many organisms. Detailed studies, particularly of the human NMNATs, have revealed distinct isoform-specific characteristics relating to enzyme kinetics and substrate specificity, oligomeric assembly as well as subcellular and tissue distribution. Moreover, direct functional relationships between NMNATs and major NAD-mediated signaling processes have been discovered suggesting that at least some of these proteins might play more than just an enzymatic role. Several investigations have also pointed to a critical role of NMNATs in pathological states such as cancer and neurodegeneration. This article intends to provide a comprehensive overview of the family of NMNATs and highlights some of the recently identified functional roles of these enzymes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273075     DOI: 10.2741/3252

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  65 in total

1.  Isoform-specific targeting and interaction domains in human nicotinamide mononucleotide adenylyltransferases.

Authors:  Corinna Lau; Christian Dölle; Toni I Gossmann; Line Agledal; Marc Niere; Mathias Ziegler
Journal:  J Biol Chem       Date:  2010-04-13       Impact factor: 5.157

Review 2.  Subcellular compartmentalization of NAD+ and its role in cancer: A sereNADe of metabolic melodies.

Authors:  Yi Zhu; Jiaqi Liu; Joun Park; Priyamvada Rai; Rong G Zhai
Journal:  Pharmacol Ther       Date:  2019-04-08       Impact factor: 12.310

3.  The dynamic regulation of NAD metabolism in mitochondria.

Authors:  Liana Roberts Stein; Shin-ichiro Imai
Journal:  Trends Endocrinol Metab       Date:  2012-07-21       Impact factor: 12.015

Review 4.  Wld(S), Nmnats and axon degeneration--progress in the past two decades.

Authors:  Yan Feng; Tingting Yan; Zhigang He; Qiwei Zhai
Journal:  Protein Cell       Date:  2010-02-23       Impact factor: 14.870

Review 5.  NAD(+)/NADH and skeletal muscle mitochondrial adaptations to exercise.

Authors:  Amanda T White; Simon Schenk
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-03-20       Impact factor: 4.310

6.  N-terminal protein acetylation by NatB modulates the levels of Nmnats, the NAD+ biosynthetic enzymes in Saccharomyces cerevisiae.

Authors:  Trevor Croft; Padmaja Venkatakrishnan; Christol James Theoga Raj; Benjamin Groth; Timothy Cater; Michelle R Salemi; Brett Phinney; Su-Ju Lin
Journal:  J Biol Chem       Date:  2020-04-16       Impact factor: 5.157

7.  Hyperthermophilic Archaeon Thermococcus kodakarensis Utilizes a Four-Step Pathway for NAD+ Salvage through Nicotinamide Deamination.

Authors:  Shin-Ichi Hachisuka; Takaaki Sato; Haruyuki Atomi
Journal:  J Bacteriol       Date:  2018-05-09       Impact factor: 3.490

Review 8.  A possibility of nutriceuticals as an anti-aging intervention: activation of sirtuins by promoting mammalian NAD biosynthesis.

Authors:  Shin-Ichiro Imai
Journal:  Pharmacol Res       Date:  2010-01-18       Impact factor: 7.658

Review 9.  Nicotinamide/nicotinic acid mononucleotide adenylyltransferase, new insights into an ancient enzyme.

Authors:  Rong Grace Zhai; Menico Rizzi; Silvia Garavaglia
Journal:  Cell Mol Life Sci       Date:  2009-05-16       Impact factor: 9.261

10.  Poly(ADP-ribose) polymerase 1 at the crossroad of metabolic stress and inflammation in aging.

Authors:  Matthias Altmeyer; Michael O Hottiger
Journal:  Aging (Albany NY)       Date:  2009-05-20       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.